Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Blood

• Publication date

  2013-01-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2012-04-422691PMID 23212523PMCID PMC3548168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

  2012cited by this paper
• Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906

  2011cited by this paper
• Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

  2011cited by this paper
• Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.

  2010cited by this paper
• Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.

  2010cited by this paper
• Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

  2010cited by this paper
• Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

  2010cited by this paper
• Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

  2009cited by this paper
• A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

  2009cited by this paper
• JAK mutations in high-risk childhood acute lymphoblastic leukemia

  2009cited by this paper
• Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

  2009cited by this paper
• Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

  2009cited by this paper
• Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia

  2009cited by this paper
• BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

  2008cited by this paper
• Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

  2008cited by this paper
• Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.

  2008cited by this paper
• Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

  2008cited by this paper
• Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

  2007cited by this paper
• SNPdetector: A Software Tool for Sensitive and Accurate SNP Detection

  2005cited by this paper
• Diagnosis of multiple cancer types by shrunken centroids of gene expression

  2002cited by this paper

• Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia.

  2026cites this paper
• IRF2BP2::JAK2 Defines a Novel Kinase‐Activating Fusion in Pediatric T‐Cell Acute Lymphoblastic Leukemia

  2026cites this paper
• Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children’s Oncology Group report

  2025cites this paper
• Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy Strategy

  2025cites this paper
• From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents

  2025cites this paper
• Targeting Senescent Stemlike Subpopulations in Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia.

  2025cites this paper
• A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia.

  2025cites this paper
• The Evolving Role of Hematopoietic Stem Cell Transplantation in Philadelphia-like Acute Lymphoblastic Leukemia: From High-Risk Standard to Precision Strategies

  2025cites this paper
• Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia

  2024cites this paper
• Barriers and facilitators to implementing adaptive trial designs in paediatric critical care: an international mixed-methods study

  2024cites this paper
• Precision Medicine for Acute Lymphoblastic Leukemia in Children: A Review

  2024cites this paper
• SOHO State of the Art Updates and Next Questions | Approach to BCR::ABL1-Like Acute Lymphoblastic Leukemia.

  2024cites this paper
• How I Treat Philadelphia Chromosome-like Acute Lymphoblastic Leukemia in Children, Adolescents, and Young Adults.

  2024cites this paper
• Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia

  2024cites this paper
• The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph‐like ALL

  2024cites this paper
• Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant—review article

  2023cites this paper
• Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia

  2023cites this paper
• A surrogate molecular approach for the detection of Philadelphia chromosome–like B‐acute lymphoblastic leukemia

  2023cites this paper
• Philadelphia Chromosome Positive and Philadelphia-Like Acute Lymphoblastic Leukemia in Children and Adolescents: Current Management, Controversies and Emerging Concepts

  2023cites this paper
• Ph-like acute lymphoblastic leukemia in adults: understanding pathogenesis, improving outcomes, and future directions for therapy

  2023cites this paper
• Pathway Analysis for Cancer Research and Precision Oncology Applications.

  2022cites this paper
• Clinical screening for Ph-like ALL and the developing role of TKIs.

  2022cites this paper
• Efficacy of ruxolitinib in acute lymphoblastic leukemia: A systematic review.

  2022cites this paper
• JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies

  2022cites this paper
• Treatments of Ph-like acute lymphoblastic leukemia: a real-world retrospective analysis from a single large center in China

  2022cites this paper
• The current treatment approach to adolescents and young adults with acute lymphoblastic leukemia (AYA-ALL): challenges and considerations

  2022cites this paper
• Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies

  2022cites this paper
• An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia

  2022cites this paper
• Treatment of Ph-Like Acute Lymphoblastic Leukemia

  2022cites this paper
• Molecular Pathways and Targets in B-Cell Progenitor Acute Lymphoblastic Leukemia

  2022cites this paper
• Are we ABL to do better for children with BCR-ABL1-like acute lymphocytic leukaemia?

  2021cites this paper
• Precursor B‐cell acute lymphoblastic leukaemia—a global view

  2021cites this paper
• Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?

  2021cites this paper
• Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted Therapy.

  2021cites this paper
• Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like—Recent Progress in Treatment

  2021cites this paper
• Acute Leukemias

  2021cites this paper
• Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia

  2021influential citation
• Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia

  2021cites this paper
• In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALL

  2021cites this paper
• Investigational treatment options in phase I and phase II trials for relapsed or refractory acute lymphoblastic leukemia in pediatric patients

  2021cites this paper
• Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions

  2021cites this paper
• Clinical Efficacy of Ruxolitinib Monotherapy and Haploidentical Hematopoeitic Stem Cell Transplantation in a Child with Philadelphia Chromosome‐like Relapsed/Refractory acute lymphoblastic leukemia

  2021cites this paper
• Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments

  2021cites this paper
• In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapy

  2021cites this paper
• BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy.

  2020cites this paper
• The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia

  2020cites this paper
• The Genomic Landscape of Pediatric Acute Lymphoblastic Leukemia and Precision Medicine Opportunities.

  2020cites this paper
• Philadelphia-Like Acute Lymphoblastic Leukemia: A Systematic Review.

  2020cites this paper
• Ph-Like ALL: Diagnosis and Management

  2020cites this paper
• Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia.

  2020cites this paper
• BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy.

  2020cites this paper
• Online informatics resources to facilitate cancer target and chemical probe discovery.

  2020cites this paper
• Prevalence and Clinical Outcome of Philadelphia-Like Acute Lymphoblastic Leukemia: Systematic Review and Meta-analysis.

  2019cites this paper
• Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children

  2019cites this paper
• Ushering in the next generation of precision trials for pediatric cancer

  2019cites this paper
• BCR-ABLl-like pediatric acute lymphoblastic leukemia

  2019cites this paper
• Hematopoietic cell transplantation consideration for Philadelphia-like acute lymphoblastic leukemia patients.

  2019cites this paper
• Myeloid loss of Beclin 1 promotes PD-L1hiprecursor B Cell lymphoma development.

  2019cites this paper
• Multi-omic approaches to improve outcome for T-cell acute lymphoblastic leukemia patients.

  2019cites this paper
• How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia

  2019cites this paper
• BCR-ABL1-like B-Acute Lymphoblastic Leukemia/Lymphoma: A Comprehensive Review.

  2019cites this paper
• The Biology of B-Progenitor Acute Lymphoblastic Leukemia.

  2019influential citation
• Pediatric Acute Lymphoblastic Leukemia: Recent Advances for a Promising Future

  2019cites this paper
• Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children’s Oncology Group Studies P9904 and P9905

  2019cites this paper
• How advanced are we in targeting novel subtypes of ALL?

  2019cites this paper
• Ph染色体样急性淋巴细胞白血病的研究进展

  2019cites this paper
• Why and how to treat Ph-like ALL?

  2018cites this paper
• Adolescent and Young Adult Cancer Biology.

  2018cites this paper
• Using genomics to define pediatric blood cancers and inform practice.

  2018cites this paper
• Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options.

  2018cites this paper
• Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

  2018cites this paper
• SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia

  2018cites this paper
• Leukämien und Lymphome

  2018cites this paper
• mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL

  2018cites this paper
• Update in Pediatric Oncology: Section A-New Developments in the Treatment of Pediatric Acute Lymphoblastic Leukemia

  2018cites this paper
• Philadelphia-like acute lymphoblastic leukemia: diagnostic dilemma and management perspectives.

  2018cites this paper
• Characteristics and Therapeutic Targeting of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.

  2018cites this paper
• Exploring the Pre-B receptor checkpoint as a therapeutic target in acute lymphoblasic leukaemia

  2018cites this paper
• Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia

  2018cites this paper
• Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.

  2018cites this paper
• BCR-ABL (Ph)-like acute leukemia-Pathogenesis, diagnosis and therapeutic options.

  2017cites this paper
• Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies

  2017cites this paper
• Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

  2017cites this paper
• BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.

  2017cites this paper
• Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways.

  2017cites this paper
• Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype.

  2017cites this paper
• CD36-positive B-lymphoblasts Predict Poor Outcome in Children With B-lymphoblastic Leukemia

  2017cites this paper
• The Role of Hematopoietic Stem-Cell Transplantation in First Remission in Pediatric Acute Lymphoblastic Leukemia: A Narrative Review

  2017cites this paper
• Philadelphia Chromosome–like Acute Lymphoblastic Leukemia

  2017cites this paper
• How is the Ph-like signature being incorporated into ALL therapy?

  2017cites this paper
• Molecular Biology of Leukemias

  2017cites this paper
• The biology of Philadelphia chromosome-like ALL.

  2017cites this paper
• Novel therapy for childhood acute lymphoblastic leukemia

  2017influential citation
• Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.

  2017cites this paper
• A Comprehensive Review

  2017cites this paper
• Philadelphia chromosome-like acute lymphoblastic leukemia.

  2017cites this paper
• [Research progress in Ph-like childhood acute lymphoblastic leukemia].

  2017cites this paper
• Precision medicine in pediatric oncology

  2017influential citation
• Implicación de las alteraciones en el número de copias en el pronóstico y progresión de la leucemia aguda linfoblástica de línea B del adulto

  2017cites this paper
• The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia

  2017cites this paper